Skip to content

Released Nov 12, 2015, after the close

10-Q filed Nov 12, 2015, 43 days after period end · 0001144204-15-064690

Q3 2015 · 10-Q
Revenue—
Net Income-$6.37MN/M vs Q3 2014N/M vs Q2 2015
EPS Diluted-$0.35N/M vs Q3 2014N/M vs Q2 2015
Operating Income-$6,433,988N/M
Operating Cash Flowderived-$5,557,897N/M
Free Cash Flowderived-$5,571,808N/M

What the release said

The release

Same quarter

MetricQ3 2015Q3 2014Q3 2013Q3 2012
Revenue——$0.00$0.00
Net Income-$6.37M-$4.09M-$3.48M-$1.01M
EPS Diluted-$0.35-$0.32-$0.39-$0.23

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR